Dr Mark giembycz
Current affiliation: Univerdsity of Calgary
Primary location: Canada
An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, tran...
Published in:British Journal of Pharmacology
Publication date:2015-01-08Pharmacodynamics of GR-mediated gene expression
The long-acting β2-adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a...
Published in:British Journal of Pharmacology
Publication date:2015-03-24Enhancement of GR-mediated gene expression by indacaterol
Theophylline and Isoenzyme-Selective Phosphodiesterase Inhibitors
Published in:Allergy and Allergic Diseases
Publication date:Not available
Airways Smooth Muscle
Published in:Not available
Publication date:1994-01-01
Rhinitis: Immunopathology and Pharmacotherapy
Published in:Not available
Publication date:1996-01-01
Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends
Published in:Not available
Publication date:2000-01-01
Airways Smooth Muscle: Neurotransmitters, Amines, Lipid Mediators and Signal Transduction
Published in:Not available
Publication date:1995-01-01
Airways Smooth Muscle: Peptide Receptors, Ion Channels and Signal Transduction
Published in:Not available
Publication date:1995-01-01
Airways Smooth Muscle: Development, and Regulation of Contractility
Published in:Not available
Publication date:1994-01-01
Airways Smooth Muscle: Modelling the Asthmatic Response In Vivo
Published in:Not available
Publication date:1996-01-01
Airways Smooth Muscle: Biochemical Control of Contraction and Relaxation
Published in:Not available
Publication date:1994-01-01
Alkylxanthines and Phosphodiesterase 4 Inhibitors for Allergic Diseases
Published in:Allergy Frontiers: Therapy and Prevention
Publication date:2009-01-01
Interaction of PDE4 Inhibitors with Enzymes and Cell Functions
Published in:Phosphodiesterase Inhibitors
Publication date:1996-01-01
Phosphodiesterase inhibitors for respiratory diseases
Published in:High Throughput Screening for Novel Anti-Inflammatories
Publication date:2000-01-01
Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors
Published in:Current Opinion in Pharmacology
Publication date:2005-06-01
Phosphodiesterase 7 (PDE7) as a therapeutic target
Published in:Drugs of the Future
Publication date:2006-01-01
Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking?
Published in:British Journal of Pharmacology
Publication date:2009-01-29Commentary
Selective Phosphodiesterase Inhibitors in the Therapy of Asthma
Published in:Clinical Immunotherapeutics
Publication date:1995-06-01
4D or not 4D – the emetogenic basis of PDE4 inhibitors uncovered?
Published in:Trends in Pharmacological Sciences
Publication date:2002-12-01
Are eosinophils out of asthma?
Published in:Trends in Pharmacological Sciences
Publication date:2001-02-01
Choking the breath out of respiratory diseases!
Published in:Trends in Pharmacological Sciences
Publication date:2001-05-01
Phosphodiesterase 4 and tolerance to β2-adrenoceptor agonists in asthma
Published in:Trends in Pharmacological Sciences
Publication date:1996-09-01
Reinventing the Wheel
Published in:Cyclic Nucleotide Phosphodiesterases in Health and Disease
Publication date:2006-12-05Nonselective Phosphodiesterase Inhibitors for Chronic Inflammatory Diseases
Mitogen-Activated Protein Kinase Activation in Eosinophils
Published in:Asthma
Publication date:Not available
Human Eosinophil Isolation and the Measurement of Apoptosis
Published in:Asthma
Publication date:Not available
Antispasmogenic activity of phosphodiesterase inhibitors in guinea-pig trachea
Published in:Pharmacological Research
Publication date:1995-01-01
Phosphodiesterase 4 and tolerance to β2-adrenoceptor agonists in asthma
Published in:Trends in Pharmacological Sciences
Publication date:1996-09-01
Current concepts on mechanisms of force generation and maintenance in airways smooth muscle
Published in:Pulmonary Pharmacology
Publication date:1992-12-01
Forskolin inhibits leukotriene D4-induced thromboxane B2 release from guinea-pig lung parenchyma
Published in:Prostaglandins & Other Lipid Mediators
Publication date:1984-11-01
Prostanoid receptor antagonists: development strategies and therapeutic applications
Published in:British Journal of Pharmacology
Publication date:2009-09-01
GS-5759, a Bifunctional β 2 -Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Ob...
Published in:Journal of Pharmacology and Experimental Therapeutics
Publication date:2016-12-07